Hepatitis C virus-specific immune responses in noninjecting drug users.
Hepatitis C virus-specific immune responses in noninjecting drug users.
复制标题
非注射吸毒者的丙型肝炎病毒特异性免疫反应。
DOI：
10.1111/j.1365-2893.2011.01573.x
复制
发表时间：
2012
影响因子：
2.5
通讯作者：
Talal,AH
中科院分区：
文献类型：
--
作者：
Zeremski,M;Makeyeva,J;Arasteh,K;DesJarlais,DC;Talal,AH
Noninjection drug use, although recognized as an emerging risk factor for acquisition of other blood‐born pathogens, is still unconfirmed as a route of hepatitis C virus (HCV) transmission. Our goal was to measure HCV exposure and prevalence in noninjection drug users (NIDUs). Fifty‐seven NIDUs were screened by extensive questionnaire to exclude prior injection drug use and evaluated for HCV‐specific serologic and cellular immune responses. HCV‐specific T‐cell responses were measured using interferon‐gamma (IFN‐γ) enzyme‐linked immunospot (ELISpot) assay with overlapping HCV peptides covering the entire HCV genome. Fifteen individuals who never used illicit drugs served as negative controls. Eleven people with no history of injecting drug use (19.3%) were HCV seropositive: seven with chronic HCV infection and four with previously resolved infection. Of 51 NIDUs with ELISpot results, HCV‐specific cellular immunity was detected in 5 (9.8%). These responses were relatively weak and narrow. We did not find significant associations between HCV‐specific immune responses and noninjection drug use practices. Subjects with HCV‐specific immunity, however, were significantly more likely to have bought sex in the past 6 months, to have had more casual partners of the opposite sex in the last 6 months, and those partners were more likely to have ever injected drugs compared to subjects without HCV‐specific immunity. In summary, we found serologic or cellular HCV‐specific immune responses in 27.5% of NIDUs. Our results suggest that sexual behaviour associated with noninjection drug use might be a risk factor for HCV acquisition. Additional studies are needed to precisely determine the practices that lead to HCV exposure among this population.
登录
查看更多内容
加纳孕妇和献血者丙型肝炎病毒感染的患病率和基因型。
影响因子：
2.2
作者：
M. H. Wansbrough;E. Frimpong;B. Cant;K. Harris;M.R.W. Evans;C. Teo
通讯作者：
C. Teo
影响因子：
32.4
作者：
Erickson, AL;Kimura, Y;Walker, CM
通讯作者：
Walker, CM
影响因子：
2.5
作者：
D. Lavanchy;R. Purcell;F. Hollinger;C. Howard;A. Alberti;M. Kew;G. Dusheiko;M. Alter;E. Ayoola;P. Beutels;R. Bloomer;B. Ferret;R. Decker;R. Esteban;O. Fay;H. Fields;E. Fuller;P. Grob;M. Houghton;N. Leung;S. Locarnini;H. Margolis;A. Meheus;T. Miyamura;M. Mohamed;B. Tandon;D. Thomas;H. T. Head;A. Toukan;P. Damme;A. Zanetti;R. Arthur;M. Couper;R. Amelio;J. Emmanuel;K. Esteves;P. Gavinio;E. Griffiths;Z. Hallaj;C. Heuck;D. Heymann;S. Holck;M. Kane;L. Martinez;F. Meslin;I. Mochny;A. Ndikuyeze;A. Padilla;G. Rodier;C. Roure;F. Savage;G. Vercauteren
通讯作者：
D. Lavanchy;R. Purcell;F. Hollinger;C. Howard;A. Alberti;M. Kew;G. Dusheiko;M. Alter;E. Ayoola;P. Beutels;R. Bloomer;B. Ferret;R. Decker;R. Esteban;O. Fay;H. Fields;E. Fuller;P. Grob;M. Houghton;N. Leung;S. Locarnini;H. Margolis;A. Meheus;T. Miyamura;M. Mohamed;B. Tandon;D. Thomas;H. T. Head;A. Toukan;P. Damme;A. Zanetti;R. Arthur;M. Couper;R. Amelio;J. Emmanuel;K. Esteves;P. Gavinio;E. Griffiths;Z. Hallaj;C. Heuck;D. Heymann;S. Holck;M. Kane;L. Martinez;F. Meslin;I. Mochny;A. Ndikuyeze;A. Padilla;G. Rodier;C. Roure;F. Savage;G. Vercauteren
感染细胞中小鼠肝炎病毒 mRNA 2 编码的 30 kDa 非结构蛋白的鉴定和稳定性
影响因子：
3.7
作者：
P. Bredenbeek;A. F. Noten;Marian C. Horzinek;W. Spaan
通讯作者：
W. Spaan
影响因子：
3.8
作者：
Lu, Ling;Li, Chunhua;Nelson, Kenrad E.
通讯作者：
Nelson, Kenrad E.